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1. Introduction  
Pulmonary resection is the first therapeutic option of various lung pathologies, among 
which localized non-microcytic bronchogenic carcinoma is the most prevalent. Due to the 
fact that many patients who develop non-microcytic bronchogenic carcinoma present 
significant comorbidity, lung resection is associated with an increased risk (between 2 and 
5%) of perioperative death (Little et al., 2005). Therefore, it is important to assess the 
patient's operability, which is defined as the ability to survive the lung resection without 
leaving any disabling sequelae.  
As most of these patients are or have been smokers, many of them have varying degree of 
obstructive lung disease. It is known that the pulmonary obstruction increases the risk of 
lung resection (Miller et al., 1981), which is why the decision to perform resection 
depends largely on the functional integrity of the lung not affected by tumor. As the 
excision supposes a loss of lung function, many years of research have led to a reasonably 
solid scientific evidence that the postoperative risk depends on post-surgery lung 
function, which can be estimated preoperatively by knowing the amount of tissue to be 
resected basing on  anatomical size or quantifying it by perfusion scintigraphy  (Wernly et 
al., 1980). 
On the other hand, it is also known that the functional capacity measured by exercise tests is 
associated with postoperative mortality (Puente & Ruiz., 2003). This has led to the 
development of integrated strategies in which basal functional tests are followed by 
postoperative function estimate and, in borderline patients, by stress testing (Marshall & 
Olsen 1993).  
2. Perioperative pulmonary physiology 
The major cardiopulmonary complications that alter normal lung function occur as a result 
of surgery (thoracotomy and resection of lung parenchyma) and anaesthesia (table 1). The 
thoracic surgery causes restrictive changes in the lung function characterized by moderate to 
severe reductions (50%) in vital capacity and up to 70% decrease of functional residual 
capacity (FRC). As a result of the  FRC decrease, the volume of airway closure is shifted, so 
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in the areas of pulmonary decline the end point of exhalation  is below the closure volume, 
which causes an early closure of the airway and, therefore, of the areas of atelectasis. The 
factors that reduce FRC include supine position, pain, general anaesthesia and obesity. 
These functional changes occur without apparent obstruction of the airway, so that the ratio 
of forced expiratory volume in one second (FEV1) and forced vital capacity (FVC) does not 
decrease. 
The action of the anaesthetic and the muscle relaxant used in the surgical procedure, 
involves a decrease in lung volumes. In addition, the effects of these drugs on the 
diaphragm and the bulbar center responsible for regenerating respiratory impulses are the 
main reasons that justify changes in lung volumes. 
The cause of the diaphragm muscle dysfunction is not clear yet. Direct damage to the 
muscles during the surgical intervention has been proposed as one of possible mechanisms, 
but transdiaphragmatic pressure measurements during maximal phrenic nerve stimulation 
suggest that the depression of the central nervous system efferent traffic on the diaphragm 
occurs as a result of inhibitory reflexes associated with pain and other stimuli to 
sympathetic or vagal receptors.  
Hypoxemia and arterial hypercapnia  that appear, especially in the postoperative period, are 
mainly due  to the effects of anaesthesia used during the surgery and cause a decrease in the 
interrelation  ventilation/perfusion (V/Q), and besides lead to deterioration of hypoxic 
pulmonary vasoconstriction, alveolar hypoventilation or low cardiac output.  The gas 
exchange disorder is intensified with combination of hypoventilation, increase in dead space 
ventilation, rapid shallow breathing and a decrease in mixed venous oxygen saturation due 
to low cardiac output, anemia and arterial desaturation and increased peripheral oxygen 
consumption with pain, fever or stress (Beckles et al., 2003). 
 
Lung function changes with anesthesia and surgery 
Impairment of gas exchange 
Reduction in lung volumes 
Dysfunction of the diaphragm 
Depression of ventilatory control 
Inhibition of cough and mucociliary system 
Table 1. Mechanism of lung function changes with anesthesia and surgery (Swenson, 1999). 
Ventilatory depression is also typical of the postoperative period and is marked by the 
residual effects of anaesthesia that inhibit normal response to hypoxia and hypercapnia. 
Analgesics and other sedatives may enhance these effects, and impede the implementation 
of pulmonary rehabilitation. They can rarely lead to episodes of sleep apnea. 
The lung defends itself from attacks of infectious and environmental agents with cough and 
mucociliary clearance. The former is suppressed both with excessive and poor pain 
treatment. The latter can be altered by an ineffective cough, limited by restrictive changes 
and weakened respiratory muscles and also by atelectasis and dysfunction and ciliary 
damage caused by anaesthetic gases (Swenson, 1999). 
Finally, it should be noted that many of these functional alterations may come as a result of 
postoperative complications such as atelectasis, infections, respiratory failure or 
exacerbations of chronic obstructive lung disease (table 2). 
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Infection (Pneumonia or bronchitis) 
Bronchospam 
Respiratory failure 
Prolonged mechanical ventilation 
Exacerbation of chronic lung disease 
Pulmonary embolism 
Obstructive sleep apnea
Specific thoracic surgical complications
Pleural effusion 
Phrenic nerve injury 
Bronchopleural fistula and empyema 
Sternal wound infection 
Gastroesophafeal anastomotic leak
Table 2. Postoperative pulmonary complications in patients with thoracic surgery (Swenson, 
1999). 
3. Lung function tests 
In the preoperative thoracic surgery the functional assessment schemes have varied over the 
past 50 years. Most respirotary function tests which were utilized in order to minimize 
morbidity and postoperative mortality (table 3) are no longer used today, being replaced by 
simpler techniques that provide similar or better information. Today the process of lung 
function assessment is spread out over several phases comprising a series of breathing tests 
that the patients scheduled for thoracic surgery will be given according to their baseline 
pulmonary function and the amount of lung tissue for resection. These steps complement 
each other, so that the degree of severity of impairment of lung function is the fact that 
determines whether or not to go a step higher. 
   
Pulmonary function test Parameter
Spirometry 
Lung  volumes 













% Perfusion en each lung 




Table 3. Pulmonary function test used in the preoperative assessment. FVC: Forced vital 
capacity. FEV1: Forced expiratory volume in 1 second. ppo: postoperative. TLC: Total lung 
capacity. RV: Residual volumen. DLCO: Diffusion capacity of the lung for carbon monoxide. 
PaO2: Oxygen partial pressure of artery. PaCO2: Carbon dioxide partial pressure of artery. 
PAP: Pulmonary artery pressure. PVR: Pulmonary vascular resistance. VO2: Oxygen uptake. 
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Spirometry is a simple, inexpensive test of high reproducibility, easy to perform. From the 
standpoint of the preoperative evaluation the most important variables are the FEV1 and 
FVC. In the early 1950s spirometry was already considered as the most valid technique to 
assess morbidity and postoperative mortality in the thoracic surgery. 
The first authors who used the predictive power of FEV1 in such surgery observed that the 
complications derived from the resection of bronchial carcinoma were associated with 
absolute values of FEV1 lower than 2 liters (Boushy et al., 1971). Subsequently, the 
measurements of spirometry were combined with those of lung volumes and there was 
observed an increase in complications with a FEV1 less than 1.20 liters, reserve volume (RV) 
greater than 3.30 liters and total lung capacity (TLC) greater than 7.90 liters (Lockwood, 
1973). On the other hand, there was an attempt to link the value of FEV1 with the type of 
lung resection and it was noticed that the requirement for pneumonectomy was a FEV1 
more than 2 liters, for lobectomy more than 1 liter and for segmentectomy or wedge 
resection more than 0.6 liter (Miller et al., 1981). 
Considering FEV1 in absolute values can lead to errors in the estimation of lung function, 
especially in patients of advanced age or low height. In this sense, there have been some 
studies whose data contemplate a reduction in complications when the FEV1 is greater than 
60% (Richter et al., 1997) or 89 ± 19% (Wang et al., 2000) of predicted values (table 4). 
Therefore, it is preferable to place greater emphasis on FEV1 percentage value in relation to 
its theoretical value than to the absolute one. In addition, the highest possible FEV1 will be 
chosen using the available therapeutic arsenal (smoking cessation, pulmonary rehabilitation 
or drug treatment with bronchodilators or corticosteroids). Finally, we could say that for 
thoracic surgery the advisable value of FEV1 is greater than or equal to 80%. 
 
 
Table 4. Preoperative lung function variables in relation to complications. FEV1: Forced 
expiratory volume in 1 second. FVC: Forced vital capacity. RV: Residual volume. TLC: Total 
lung capacity. DLCO: Diffusion capacity of the lung for carbon monoxide. VA: Alveolar 
volume. ns: not significant (Wang et al., 2000). 
In the algorithms used for the functional assessment of candidates for lung resection, the 
value of postoperative FEV1 (ppo-FEV1) plays an important role in the alternative to 
perform further tests or exclude patients from surgery without performing these tests 
(Wyser et al., 1999) (figure 1). In this sense, a value of ppo-FEV1 less than 40% of predicted 
increases the risk of perioperative complications and mortality by 16-50% (Pierce et al., 
1994), being higher (60%) when ppo-FEV1 is less than 30% (Nakahara et al., 1985). 
Even today there is a disagreement about whether ppo-FEV1 is a good predictor of 
perioperative complications or not. It has been seen that ppo-FEV1 is not a good predictor of 
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complications in patients with preoperative FEV1 greater than 70%. In addition, among 
these patients, who also have ppo-FEV1 less than 40%, the mortality is 4.8%. These findings 
explain the so-called "lung volume reduction effect", which shows a reduction of functional 
loss in patients with airflow limitations, such as, for example, in patients with chronic 
obstructive lung disease (COPD) (Sekine et al., 2003). 
A ppo-FEV1 value of 40% is currently being used to distinguish between normal and high 
risk of complications in thoracic surgery. However, due to improvements in surgical 
techniques and perioperative management, the value of ppo-FEV1 could fall to 30%. 
Although the ppo-FEV1 is fairly accurate in predicting the final residual value of FEV1 
within 3-6 months after thoracic surgery, the real value of FEV1 is overestimated in the first 
postoperative days, when most of the complications occur. In this regard, it has been shown 
that the first postoperative day and after a lobecctomia the real value of FEV1 was 30% 
lower than expected. Therefore, it would be a better predictor of complications than the 
ppo-FEV1 was (Varela et al., 2007). 
The current recommendations of the ERS / ESTS Task Force are that the ppo-FEV1 should 
not only be used to select patients with pulmonary cancer for lung resection, especially in 
patients with moderate or severe COPD. It is known that in patients with COPD it is likely 
to overestimate the loss of lung function in the early postoperative stages and ppo-FEV1 
does not seem to be a reliable predictor of complications. Finally, a value of ppo-FEV1 less 
than 30% predicted would be a high risk parameter when included in an algorithm for 
assessing pulmonary reserve before thoracic surgery (Brunelli et al., 2009). 
3.2 Diffusing capacity of the lung for carbon monoxide 
The DLCO represents the amount of carbon monoxide trapped by the lungs after inspiration 
of a small amount of this gas. This test provides us with information about the alveolo-
capillary membrane, which is responsible for alveolar oxygen exchange. Thus, the DLCO is 
used to evaluate the surgical risk in patients scheduled for thoracic surgery. 
Although DLCO is a technique which allows to estimate the risk of postoperative 
complications, it is not as well studied as FEV1. Several studies have shown that a 
preoperative DLCO less than 60% predicted was associated with increased mortality and 
postoperative complications were increased when the DLCO was less than 80% of predicted 
value (Ferguson et al., 1998). It has also been observed that patients with decreased DLCO 
(65.3 ± 5.0%) had more respiratory complications than those with normal DLCO (90.1 ± 
5.9%) (Wang et al., 1999). In addition, decreased DLCO is related to an increase in the 
frequency of hospital readmissions and poor quality of life for the long term. 
Therefore, the DLCO is an additional test to spirometry in which if a patient's preoperative 
functional evaluation has a FEV1 and DLCO greater than or equal to 80%, no additional 
testings are required. But if a patient has a DLCO lower than 80% despite a FEV1 greater 
than or equal to 80%, additional tests should be performed to make sure that it is a good 
candidate for thoracic surgery. This indicates that the DLCO is an important test to predict 
postoperative complications both in patients without COPD as well as in patients suffering 
from this pathology (Ferguson et al., 2008). 
On the other hand, a value of postoperative DLCO (ppo-DLCO) of 40% is currently being 
used to distinguish between normal and high risk of complications in patients undergoing 
lung resection (Wyser et al., 1999) (figure 1). However, taking into account advances in 
perioperative care and surgical techniques, the allowed limit of ppo-DLCO should be 
lowered to 30%. 
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Fig. 1. Proposed algorithm for the assessment of the cardio-respiratory reserves of lung 
resection candidates. Tl 5 thallium; Tc 5 technetium. ECG: electrocardiogram. FEV1: Forced 
expiratory volume in 1 second. DLCO: Diffusion capacity of the lung for carbon monoxide. 
ppo: postoperative. VO2: Oxygen uptake. (Wyser et al., 1999). 
The current recommendations of the ERS / ESTS Task Force indicate that the DLCO should 
be a routine measurement of functional evaluation of candidates for lung resection, 
especially if the spirometry is altered. The threshold value of ppo-DLCO of 30% is high risk 
when included in an algorithm for the assessment of pulmonary reserve before thoracic 
surgery (Brunelli et al., 2009). 
3.3 Measurement of gas exchange 
Arterial gasometry, is a test that is requested routinely in patients about to undergo thoracic 
surgery. Unlike spirometry, arterial blood gases values provide some more direct 
information about the problem with the gas exchange that is often present in this type of 
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surgery. However, they do not provide as useful measurement as FEV1 or DLCO in the 
perioperative functional assessment. 
In relation to arterial oxygen pressure (PaO2), few studies describe the exact role of this 
parameter in the assessment of perioperative risk. In some of them it has been shown that 
PaO2 below 50 mmHg is associated with postoperative complications (Mittman & 
Bruderman., 1977). Furthermore, sometimes hypoxemia in patients with bronchial 
carcinoma may be due to a shunt secondary to pulmonary atelectasis that is improved after 
the lung resection. 
With regard to the blood pressure of CO2 (PaCO2), it has been postulated that hypercapnia 
(PaCO2 greater than 45 mmHg) involves an increase in postoperative complications (Meyer-
Erkelenz et al., 1980). However, one study has demonstrated that patients with severe airflow 
obstruction (FEV1 40 ± 6%) and PaCO2 of 44 ± 4 mmHg, did not have any complications after 
lobectomy (Morice et al., 1992) (table 5). In this sense, other authors have also come to the 
conclusion that hypercapnia is not a risk factor for the presence of postoperative pulmonary 
complications (Miller et al., 1981). Therefore, although there is no consensus about the 
usefulness of the arterial gasometry in the perioperative functional assessment, it seems clear 
that hypercapnia should not exclude patients who are candidates for lung resection. 
 
 
Table 5. Relationship among spirometry, arterial blood gases and exercise testing in patients 
undergoing lung resection. FVC: Forced vital capacity. FEV1: Forced expiratory volume in 
1 s. DCO: Diffusion capacity of the lung for carbon monoxide. TLC: Total lung capacity. 
PO2: Oxygen partial pressure of artery. PCO2: Carbon dioxide partial pressure of artery. 
VO2: Oxygen uptake. RV: Right ventricule. (Morice et al., 1992). 
3.4 Quantitative ventilation/perfusion scintigraphy 
The quantitative perfusion scintigraphy is based on the radiation emitted by an isotope that 
is taken up by the lungs after being injected intravenously. The percentage of radioactivity is 
associated with lung function, the right lung being the largest (55% of the total radiation). 
The left lung is responsible for the remaining 45% (figure 2). 
The calculation of ppo-FEV1 in patients scheduled for pneumonectomy, from preoperative 
FEV1 and lung perfusion scintigraphy, is performed as follows (Kristersson et al., 1972): 
 ppo FEV1  preoperative FEV1 x % of perfusion of the undisturbed lung− =   
Therefore, if such a patient is a candidate for left pneumonectomy and has a 3-liter 
preoperative FEV1 and the scintigraphy shows 30% perfusion in the left lung and 70% in the 
right, the value of FEV1 postpneumonectomy is: 
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 ppo FEV1 3 litersx 0,7  2,1 liters− = =    
It has been shown  that there is a good relationship between the ppo-FEV1 and real 
postoperative FEV1, while the ppo-FEV1 can be 10% lower than the measured FEV1  3 
months after the surgery. 
Wernley et al. applied the method of lung perfusion scintigraphy to calculate the FEV1 after 
lobectomy with the following formula (Wernly et al., 1980): 
Estimate of the FEV1 loss  preoperative FEV1 x % affected lung perfusion x (number of
               segments in the lobe to be resected /  number of segments in the lung)
=
  
Perfusion scintigraphy has also been used to calculate ppo-DLCO, using the same formulas 
for estimating the ppo-FEV1. Therefore, the ppo-DLCO is calculated using the following 
formula: 
 ppo DLCO  preoperative DLCO x % de perfusion of the unresected lung− =   
  
 
Fig. 2. Anterior and posterior images from perfusion scintigram. Three equally sized regions of 
interest over lungs are shown. Counts in each zone are measured. Geometric means of anterior 
and posterior images are then used to calculate relative perfusion and ventilation for each zone 
for each lung. By this method, percentages are obtained for upper, middle, and lower zones of 
right and left lungs for both perfusion and ventilation. (Win et al., 2006). 
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It is difficult to establish a definitive cut-off of ppo-FEV1 or ppo-DLCO above which 
resection of lung parenchyma will be safe. Some authors have estimated 0.8 liters as the 
limit below which it is unreasonable to perform the resection of the pulmonary parenchyma 
(Olsen et al., 1974). As an absolute value it can lead to errors, which is why it is better to use 
the percentage with respect to the theoretical value. 
Several studies have shown that in candidates for lung resection, when ppo-FEV1 is greater 
than 40%, postoperative mortality is reduced (Markos et al., 1989), but other authors did not 
observe its increase when ppo-FEV1 is less than 40% (Morice et al., 1992). In relation to the 
ppo-DLCO it has also been noticed that  the risk of postoperative complications is greater 
when the ppo-DLCO is less than 40% (Markos et al., 1989), and even one study estimates 
that this parameter is the best assessment of mortality and postoperative complications 
(Ferguson et al., 2008). 
In practice, the scintigraphy has not been widely used in the functional assessment of 
patients about to undergo a lobectomy because of the difficulty in interpreting the 
individual contribution of each of the lobes to the whole of ventilation and perfusion. This 
could explain why several researchers consider that the simple calculation of the lung 
segments can predict the ppo-FEV1 as accurately as the ventilation perfusion scintigraphy 
does (Win et al., 2004). The ventilation scintigraphy has been widely used to predict 
postoperative lung function in patients with lung cancer who are scheduled for 
pneumonectomy (Colice et al., 2007). 
The correlation between current and predicted ppo-FEV1 using the ventilation/perfusion 
scintigraphy has been variable with r between 0.67 and 0.9 (Win et al., 2006a). Both the 
ventilation and perfusion scintigraphies offer a good prediction of postoperative lung 
function individually, but it seems that there is no additional benefit in the performance of 
both (Win et al., 2006). However, the interpretation of the results should take into account 
that these techniques may underestimate the actual postoperative value (Zeiher et al., 1995). 
3.5 Exercise test 
During the exercise the patient is subjected to physical stress so that the whole system that 
regulates the uptake, transport and use of oxygen can be studied through the exercise test. 
When the latter is started, the lung increases the ventilation, oxygen uptake (VO2), CO2 
production and blood flow similar to that which occurs during the postoperative period 
following the lung resection. 
Among all the variables mentioned above, the most important is the peak oxygen uptake 
(VO2 peak), which gives us an idea of the global response to the effort and is defined as the 
maximum amount of oxygen a subject can capture, transport and use during the exercise. In 
addition, during the preoperative evaluation process the VO2 peak is the parameter that 
estimates the probability of complications best of all. Despite this, the exercise test should be 
performed only in selected cases (decrease in FEV1 and/or in DLCO below 80%) (Wayser et 
al., 1999). 
3.5.1 Low-technology exercise; stair climbing, shuttle walk, and 6-min walk tests 
Six-minute walk, stair climbing and shuttle walk tests have proved to be useful for 
preoperative risk stratification. In this sense, the 6-min walk test has a high reliability in the 
estimation of VO2 peak in healthy subjects and patients with COPD or those who are about 
to undergo lung transplantation and, therefore, in assessing the postoperative risk after 
thoracic surgery (Brunelli et al, 2009). 
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The shuttle walk test appears more reproducible and highly correlated with VO2 peak, 
estimating that 25 routes in this test are equivalent to a VO2 peak of 10 mL/kg/min (Singh 
et al, 1994). This cutoff point has been included in the algorithm proposed by the British 
Thoracic Society (BTS, 2001). However, no statistically significant differences have been 
found in the shuttle walk test among patients with and without complications after lung 
resection (Win et al., 2006b). This test tends to overestimate the exercise capacity in its range 
of lower values compared to VO2 peak, concluding that it should not be used alone to 
exclude patients from surgery (BTS, 2001). It has also been observed that patients who walk 
more than 400 meters in the shuttle walk test have a VO2 peak higher than 15 mL/kg/min 
(BTS, 2001). 
The effectiveness of stair climbing test to predict serious cardiopulmonary complications 
following the lung resection surgery has already been demonstrated (Olsen et al., 1991). 
Against this background, the patients who climb less than 12 meters have a 2-fold higher 
rate of complications and mortality 23 times higher when compared with those who climb 
more than 22 meters, with a mortality rate of less than 1% (Brunelli et al., 2008). It has also 
been noticed that in patients with ppo-FEV1 or ppo-DLCO less than 40%, who climed more 
than 22 meters, the mortality rate is nonexistent (Brunelli et al., 2008).  
Oximetry during the exercise has been proposed as a useful test in the preoperative 
assessment of candidates for lung resection (Colice et al., 2007). The role of oxygen 
desaturation during the exercise in postoperative risk stratification has not been defined in 
relation to early complications after the resection. In addition, it has been seen that oxygen 
desaturation during the exercise is a good predictor of postoperative respiratory failure, 
need for admission to an Intensive Care Unit (ICU), prolonged hospital stays and home 
treatment with oxygen (Ninan et al., 1997). On the other hand, oxygen saturation below 90% 
during the exercise test with incremental protocol is not a good predictor of postoperative 
cardiopulmonary morbidity (Varela et al., 2001). 
3.5.2 High-technology exercise; cardiopulmonary exercise testing  
There are 2 types of exercise protocol that have been used to evaluate the surgical risk: 
incremental or submaximal. They are usually carried out on a bicycle or a treadmill. The 
incremental protocol is the most used and consists in increasing the work to be performed 
by each patient to the limit of his tolerance. The exercise ends when the symptoms do not 
allow the patient to continue performing the exercise or when the registered variables do 
not permit to continue the test (ATS, 2003) (table 6). 
 
 
Table 6. Indications for exercise terminations. ECG: electrocardiogram. SpO2: arterial 
oxygen saturation. (ATS, 2003).   
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The reliability of the exercise test with incremental protocol has been confirmed by 
numerous studies. In 1982 it was already proved that the complication rate decreased in 
patients with VO2 peak more than 1 liter (Eugene et al., 1982). In 1984 it was observed that 
the rate of postoperative complications was 100% when the VO2 peak was less than 15 
mL/kg/min, but if this parameter was greater than 20 mL/kg/min, the risk of 
complications was 10% (Smith et al., 1984). 
In 1992 it was found that among the patients with preoperative FEV1 less than or equal to 40%, 
ppo-FEV1 less than or equal to 33% or PaCO2 more than or equal to 45 mmHg, those who did 
not undergo a exercise test and had a VO2 peak above 15 ml/kg/min were considered 
suitable for lung resection with less postoperative complications (Morice et al., 1992). 
In 1995 with a larger group of patients, it was already found that the VO2 peak, expressed as 
a percentage of predicted, estimated better postoperative complications, and that the 
patients with a VO2 peak more than 75% had 10% probability of complications. In contrast, 
in patients with VO2 peak less than 43% this probability increased to 90%, using as the 
cutoff point the VO2 peak of 60% (Bolliger et al. 1995a). At the same time, it was observed 
that patients with complications had a VO2 peak lower than 62.8% and if postoperative VO2 
peak (ppo-VO2 peak) was less than 10 mL/kg/min, the risk of complications was very high 
(Bolliger et al., 1995b). 
Recently it has been noticed that patients with complications have a VO2 peak of 15 
mL/kg/min, while those without complications, have a VO2 peak of 19.2 mL/kg/min 
(Wang et al., 1999). Therefore, we can say that patients with a VO2 peak less than 10 
mL/kg/min are not candidates for lung resection surgery. On the contrary, they are 
candidates if the VO2 peak is more than 15 mL/kg/min. Furthermore, in connection with 
the completion of pneumonectomy, VO2 peak values above 20 mL/kg/min or 75% of 
predicted value indicate a low risk of postoperative complications, while values below 10 
mL/kg/ min or 40% of predicted indicate a high risk (Bolliger et al., 1995b). 
Trying to get a better tolerance for exercise testing, especially in patients with dyspnoea who 
were not able to reach their VO2 peak, the submaximal protocol was proposed. In it the 
patient performs a pre-defined level of work (ATS, 2003). 
After studying the exercise test with submaximal protocol in candidates for lung resection 
surgery, it has been observed that the VO2 reached allowed to predict the risk of 
postoperative complications (Miyoshi et al., 1989). However, this type of protocol usually 
requires invasive techniques which are not tolerated so well, therefore, this type of protocol 
is usually replaced by the incremental one. 
The current recommendations of the ERS / ESTS Task Force is that the cardiopulmonary 
exercise test is sure, reproducible and should be performed in a controlled environment. In 
addition, the VO2 peak measured during the test with incremental protocol should be 
considered as the most important parameter to assess, as a measure of exercise capacity and 
as a good predictor of postoperative complications after thoracic surgery. Finally, to perform 
pneumonectomy the value of 75% of predicted or more than 20 mL/kg/min should be 
considered as cutoff point. The risk of postoperative complications is high if the VO2 peak is 
less than 35% of predicted or less than 10 mL/kg/min for any resection. Instead, there is 
insufficient evidence to recommend cutoff points for lobectomy (Brunelli et al., 2009). 
3.6 Other tests 
Thoracic computed tomography (CT) has efficacy comparable to that of perfusion 
scintigraphy in the calculation of ppo-FEV1 (Wu et al., 2002). In one study that compared 
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the usefulness of thoracic CT (figure 3), single photon emission computed tomography 
(SPECT) and magnetic resonance imaging (MRI) in  patients with bronchogenic carcinoma 
who are candidates for lung resection, MRI proved to be more accurate than the other two 
techniques in the measurement of ppo-FEV1 (Ohno et al., 2007). 
 
 
Fig. 3. Quantitative CT scan shows functional lung (red), pulmonary emphysema (black), and 
lung cancer (white). (Ohno et al., 2007). 
The anatomical method is the calculation of postoperative lung function with the help of a 
formula that uses the preoperative FEV1 or FVC and the number of segments planned for 
resection (Zeiher et al., 1995). In case of lobectomy this formula estimates accurately the 
FEV1 postoperative and FCV which is not true in the case of pneumonectomy. That is why 
the latter is considered as inaccurate anatomical method. 
The studies of pulmonary hemodynamics have also been used in the reseach of respiratory 
function in lung resection candidates. Perioperative risk is estimated by measuring the 
pulmonary arterial pressure and PaO2 during temporary occlusion of the pulmonary artery. 
This technique simulates the "physiological pneumonectomy" and is performed both at rest 
and during the exercise. It has been observed that growth in pressure in the pulmonary 
artery during the occlusion period increases the postoperative risk and complications (Gass 
& Olsen 1986). In addition, it has been observed that if the pulmonary arterial pressure is 
higher than 35 mmHg and PaO2 less than 45 mmHg, the patient is inoperable (Olsen et al., 
1975). Another hemodynamic parameter used in the postoperative pulmonary assessment is 
the measurement of pulmonary vascular resistence (Schuurmans et al., 2002). 
The main drawbacks of the use of pulmonary hemodynamics are the complexity of these 
techniques and the fact that they are invasive. Currently and in practice pulmonary 
hemodynamics is rarely used in respirotary assessing of candidates for thoracic surgery 
because the noninvasive tests have proved to have equal or superior efficacy. 
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4. Algorithms in the preoperative functional assessment 
The use of algorithms in the evaluation of lung function in patients scheduled for thoracic 
surgery has as the main objective the step standardization of a series of diagnostic tests. 
These procedures avoid unnecessary costs, save time and allow you to gain experience in a 
more regulated way. This rationalization process contributes to improved patients care and 
decreased postoperative morbidity and mortality (Juliá Serdá et al., 2010). 
Although several algorithms have been proposed to assess respiratory function in patients 
undergoing thoracic surgery, there are few validations of them. In addition, they depend on 
the patients population being served and the technical possibilities of each hospital or center 
where they are performed (Juliá Serdá et al., 2010). 
One of the most widely accepted algorithms was proposed by Bolliger et al. and performed 
in 80 patients scheduled for resection of lung parenchyma (Bolliger et al. 1995a). This 
algorithm was validated later by Wyser et al. in 137 patients (figure 1), demonstrating a low 
postoperative complication rate (11%) and mortality (1.5%) (Wyser et al., 1999). 
 
 
Fig. 4. Algorithm for assessment of cardiopulmonary reserve before lung resection in lung 
cancer patients. FEV1: Forced expiratory volume in 1 s. DLCO: Diffusion capacity of the 
lung for carbon monoxide. ppo: postoperative. VO2: Oxygen uptake. (Brunelli et al., 2009) 
www.intechopen.com
 
Front Lines of Thoracic Surgery 
 
384 
Taking into account these issues the ERS / ESTS Task Force has recently published its 
algorithm based fundamentally on the performance of exercise tests when preoperative 
FEV1 or DLCO is less than 80%. If in the exercise test VO2 peak is less than 35% or 10 
mL/kg/min, it should not be recommendable to perform pneumonectomy or lobectomy, 
but if it is higher than 75% or 20 mL/kg/min, any resection (including pneumonectomy) 
would be indicated. If the VO2 peak is between these cutoff values, it would be advisable to 
calculate ppo-FEV1 and ppo-DLCO. If these are greater than 30%, lung resection would be 
indicated according to the calculated extension, and if, at least, one of these parameters is 
less than 30% it would be necessary to calculate the ppo-VO2 peak. After its calculation and 
if it is greater than 35% or 10 mL/kg/min, resection would be indicated depending on the 
calculated extension, and if its value is less than this cutoff, neither pneumonectomy nor 
lobectomy would be recommended. Finally, if it is impossible to perform cardiopulmonary 
exercise test and calculate the VO2 peak, it is recommendable to carry out the stair climbing 
test, but if the reached altitude is less than 22 meters, its calculation would be advisable 
(Brunelli et al., 2009 ) (figure 4). 
One limitation in this type of algorithms, focusing on the completion of cardiopulmonary 
exercise testing, is that some candidates for lung resection are unable to execute any kind of 
exercise test due to the burden of concomitant comorbidities. These patients have 
demonstrated increased mortality after lung resection (Brunelli et al., 2005) and, after careful 
selection based on cardiopulmonary parameters they should be considered as high-risk 
patients and candidates to be perioperatively monitored. 
5. Patient care managment 
The use of bronchodilators, corticosteroids or a combination of both, as well as pulmonary 
rehabilitation and smoking cessation can help reduce postoperative complications occurring 
after thoracic surgery, especially in patients with comorbidities who present declining 
values of FEV1 or DLCO. 
5.1 Smoking cessation 
Smokers have significantly higher risk of postoperative complications, so an intervention for 
smoking cessation during the preoperative period may be effective to reduce the incidences 
of complications. Moreover, the time of surgery may be a unique opportunity for smoking 
cessation attempts to succeed (Moller & Villebro, 2005). 
There is evidence that interventions for smoking cessation, which include nicotine 
replacement therapy (NRT), increase for a short term the rate of smoking cessation and 
decrease postoperative morbidity. In this process it remains unclear which treatment 
intensity is optimal. Derived from indirect comparisons, the interventions that begin from 4 
to 8 weeks before surgery, based on weekly counselling and the NRT are the most effective 
to quit smoking and to prevent long-term postoperative complications (Moller & Villebro, 
2005). 
5.2 Pulmonary rehabilitation 
Pulmonary rehabilitation, that includes exercise and education, is effective in candidates for 
lung volume reduction and in the pre-and postoperative period of lung transplantation 
(Nici et al., 2006). However, this effectiveness is not clearly demonstrated in surgical 
patients with lung cancer. 
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Before the surgery, the preoperative VO2 is inversely proportional to the probability of the 
presence of complications after lung resection (Wu et al., 2002), which, in turn, is associated 
with postoperative loss of lung function (Nagamatsu et al., 2007). In addition, pulmonary 
rehabilitation improves VO2 before the surgery in patients with COPD with low VO2 (less 
than 15 mL/kg/min), which reduces late complications without affecting the operability or 
the prognosis (Bobbio et al., 2008). 
Preoperative training programs lead to a reduction of hospital stay and of complications in 
patients with COPD and lung cancer (Sekine et al., 2005). However, improved accessibility 
to intervention has been observed only in patients with “quasi normal” lung function (Lovin 
et al., 2006). Pulmonary rehabilitation in inpatients has shown benefits in exercise capacity 
and lung volumes (Cesario et al., 2007). 
Therefore, in the light of the data presented, it seems logical that pulmonary rehabilitation 
may decrease the complication rate in candidates for lung resection, which is why future 
researches on the content and duration of rehabilitation programs are priorities. 
5.3 Pharmacologic therapy 
The diagnosis of COPD is often established during the preoperative functional assessment 
in patients scheduled for lung resection after the diagnosis of lung cancer. These patients, 
with a high percentage of respiratory complications, may be excluded from surgery if we 
fail to achieve, with proper treatment, a sufficient pulmonary function value. 
The main guidelines for the management of COPD patients who are to undergo lung 
resection indicate that it is necessary that the patient quit smoking, do exercises in 
pulmonary rehabilitation and optimize proper treatment to improve lung function and 
reduce postoperative complications (Brunelli et al., 2009). However, the treatments indicated 
for patients with COPD and lung cancer do not differ from those which are recommended 
to patients who have only COPD, in which a short-term therapeutic effect is not expected. 
In the scientific literature we have found only few studies that evaluate the short and long 
term effect of initiation of therapy in patients with COPD and lung cancer. Several of them 
value the effect of tiotropium on lung function, establishing its improvement up to 226ml in 
FEV1 (Kobayashi et al., 2009), but without any effect on post sugery complications (Ueda et 
al. 2010). In a recent study, the treatment with formoterol and budesonide added to 
tiotropium improved the FEV1 in 310ml and decreased the number of postoperative 
pulmonary complications (Bölükbas et al., 2011). One of the keys to these results is the 
improvement in lung function that occurs when adding corticosteroids to long-acting 
bronchodilators. Another key is the improvement in FEV1 due to these drugs, since its 
value, both pre-and postoperative, is associated with mortality and morbidity after the 
surgery. Therefore, an elevation of FEV1 can increase the number of candidates for surgical 
resection, thus optimizing the treatment of cancer and improve the prognosis of these 
patients. 
6. Conclusion  
A lot of scientific literature dedicated to pre-operative evaluation before surgical treatment 
of lung diseases has been published. The search for the ideal preoperative test to predict 
major perioperative risk of patients began with the use of spirometry in 1955. Since then, 
scientific evidence allowing the stratification of perioperative risk based in different 
preoperative pulmonary function tests, estimations of postoperative lung function, 
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pulmonary circulation hemodynamics, arterial blood gases or exercise testing has been 
given. Therefore, the functional assessment has undergone major changes; apart from 
preoperative measurement of pulmonary function (FEV1, DLCO or VO2 peak) is getting 
more and more importance. 
In the last few years, a number of decision-making algorithms interpreting the abundant 
literature on the issue have been described. These algorithms are mainly based on that 
postoperative FEV1 should not to be used alone to select patients for lung resection. DLCO 
should be routinely measured during pre-operative evaluation of lung resection candidates 
(regardless of whether the spirometric evaluation is abnormal or not). A postoperative FEV1 
and DLCO values of 30% predicted is suggested to be a high risk threshold for this 
parameter when included in an algorithm for assessment of pulmonary reserve before 
surgery, exercise tests should be indicated for all the patients undergoing surgery with FEV1 
or a DLCO < 80% of normal values and either ventilation scintigraphy or perfusion 
scintigraphy offer good prediction of post-operative lung function.  
Finally, the main recommendation to the patients on which lung resection will be performed 
is to give up smoking for sufficient spell (at least 2–4 weeks) before the surgery, since it may 
decrease post-operative complications. Moreover, early pre- and post-operative 
rehabilitation should also be recommended, since it may produce functional benefits in 
patients with resected lung. 
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whole discipline is organically presented, but authors' contributions are simply listed in their pertaining
subclasses of Thoracic Surgery. I'm sure that this original and very promising editorial format which has and
free availability at its core further increases this book's value and it will be of interest to healthcare
professionals and scientists dedicated to this field.
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